Novel ultra-cryo milling and co-grinding technique in liquid nitrogen to produce dissolution-enhanced nanoparticles for poorly water-soluble drugs

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 3, 2012, Pages 325-333

  Sugimoto, Shohei ^a   Niwa, Toshiyuki ^a   Nakanishi, Yasuo ^b   Danjo, Kazumi ^a  

^a MEIJO UNIVERSITY   (Japan)

^b Development Center   (Japan)

Author keywords

Co grinding; Cryo milling; Liquid nitrogen; Media milling; Submicron; Zirconia bead

Indexed keywords

CARBOXYMETHYLCELLULOSE; EUDRAGIT; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; LIQUID NITROGEN; MICROCRYSTALLINE CELLULOSE; NANOPARTICLE; PHENYTOIN; POVIDONE;

ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG SOLUBILITY; PARTICLE SIZE; TABLET MANUFACTURE; WETTABILITY; X RAY DIFFRACTION;

CELLULOSE; DRUG COMPOUNDING; METHYLCELLULOSE; NANOPARTICLES; NITROGEN; PARTICLE SIZE; PHENYTOIN; POVIDONE; POWDERS; SOLUBILITY; WATER; X-RAY DIFFRACTION;

EID: 84857865523     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.60.325     Document Type: Article

References (40)

1. Lipinski C., Methods and Principles in Medicinal Chemistry, 18, 215-231 (2003).
2. Van Eerdenbrugh B., Van den Mooter G., Augustijns P., Int. J. Pharm., 364, 64-75 (2008).
3. Van Eerdenbrugh B., Froyen L. Van Humbeeck J., Martens J. A., Augustijns P., Van den Mooter G., Eur. J. Pharm. Sci., 35, 127-135 (2008).
4. Wu Y., Loper A., Landis E., Hettrick L. Novak L., Lynn K., Chen C., Thompson K., Higgins R., Batra U., Shelukar S., Kwei G., Storey D., Int. J. Pharm., 285, 135-146 (2004).
5. Jimbo G., Iyaku.Journal Inc., Tokyo 1986, 168-172 (1986).
6. Junghanns J. U., Müller R. H., Int. J. Nanomedicine, 3, 295-309 (2008).
7. Jacobs C., Müller R. H., Pharm. Res., 19, 189-194 (2002).
8. Hecq J., Deleers M., Fanara D., Vranckx H., Boulanger P., Le Lamer S., Amighi K., Eur. J. Pharm. Biopharm., 64, 360-368 (2006).
9. Merisko-Liversidge E., Liversidge G. G., Cooper E. R., Eur. J. Pharm. Sci., 18, 113-120 (2003).
10. Verma S., Gokhale R., Burgess D. J., Int. J. Pharm., 380, 216-222 (2006).
11. Lee J., J. Pharm. Sci., 92, 2057-2068 (2003).
12. Van Eerdenbrugh B., Vermant J., Martens J. A., Froyen L., Van Humbeeck J., Augustijns P., Van den Mooter G., J. Pharm. Sci., 98, 2091-2103 (2009).
13. Tanaka Y., Inkyo M., Yumoto R., Nagai J., Takano M., Nagata S., Chem. Pharm. Bull., 57, 1050-1057 (2009).
14. Niwa T., Nakanishi Y., Danjo K., Eur. J. Pharm. Sci., 41, 78-85 (2010).
15. Vasserman A. A., "Izdatel'avto Nauska Moscou," 1966, pp. 253-254.
16. Brovik E. S., Sov. Phys., 5, 506-507 (1960).
17. Yamada T., Saito N., Imai T., Otagiri M., Chem. Pharm. Bull., 47, 1311-1313 (1999).
18. Mura P., Cirri M., Faucci M. T., Ginès-Dorado J. M., Bettinetti G. P., J. Pharm. Biomed. Anal., 30, 227-237 (2002).
19. Watanabe T., Hasegawa S., Wakiyama N., Kusai A., Senna M., Int. J. Pharm., 250, 283-286 (2003).
20. Moribe K., Pongpeerapat A., Tozuka Y., Yamamoto K., Pharmazie, 61, 97-101 (2006).
21. Wu J. Z., Ho P. C., Eur. J. Pharm. Sci., 29, 35-44 (2006).
22. Shudo J., Pongpeerapat A., Wanawongthai C., Moribe K., Yamamoto K., Biol. Pharm. Bull., 31, 321-325 (2008).
23. Chingunpitak J., Puttipipatkhachorn S., Chavalitshewinkoon-Petmitr P., Tozuka Y., Moribe K., Yamamoto K., Drug Dev. Ind. Pharm., 34, 314-322 (2008).
24. Sugimoto S., Niwa T., Nakanishi Y., Danjo K., Int. J. Pharm., in press (2012).
25. Wanawongthai C., Pongpeerapat A., Higashi K., Tozuka Y., Moribe K., Yamamoto K., Int. J. Pharm., 376, 169-175 (2009).
26. Crowley K. J., Zografi G., J. Pharm. Sci., 91, 492-507 (2002).
27. Suzuki H., Ogawa M., Hironaka K., Ito K., Sunada H., Drug Dev. Ind. Pharm., 27, 943-949 (2001).
28. Suzuki H., Ogawa M., Hironaka K., Ito K., Sunada H., Drug Dev. Ind. Pharm., 27, 951-958 (2001).
29. Wongmekiat A., Tozuka Y., Oguchi T., Yamamoto K., Pharm. Res., 19, 1867-1872 (2002).
30. Vogt M., Kunath K., Dressman J. B., Eur. J. Pharm. Biopharm., 68, 330-337 (2008).
31. Bahl D., Bogner R. H., AAPS PharmSciTech, 9, 146-153 (2008).
32. Chono S., Takeda E., Seki T., Morimoto K., Int. J. Pharm., 347, 71-78 (2008).
33. Bahl D., Hudak J., Bogner R. H., Pharm. Dev. Technol., 13, 255-269 (2008).
34. Vadher A. H., Parikh J. R., Parikh R. H., Solanki A. B., AAPS PharmSciTech, 10, 606-614 (2009).
35. Jagadish B., Yelchuri R., K B., Tangi H., Maroju S., Rao V. U., Chem. Pharm. Bull., 58, 293-300 (2010).
36. Barzegar-Jalali M., Nayebi A. M., Valizadeh H., Hanaee J., Barzegar-Jalali A., Adibkia K., Anoush M., Sistanizad M., J. Pharm. Pharm. Sci., 9, 307-316 (2006).
37. Garg A., Singh S., Rao V. U., Bindu K., Balasubramaniam J., Drug Dev. Ind. Pharm., 35, 455-470 (2009).
38. Pongpeerapat A., Higashi K., Tozuka Y., Moribe K., Yamamoto K., Pharm. Res., 23, 2566-2574 (2006).
39. Vogt M., Vertzoni M., Kunath K., Reppas C., Dressman J. B., Eur. J. Pharm. Biopharm., 68, 338-345 (2008).
40. Pongpeerapat A., Wanawongthai C., Tozuka Y., Moribe K., Yamamoto K., Int. J. Pharm., 352, 309-316 (2008).